Prevention of Retinal Vessel Changes Associated With Diabetic Retinopathy in Galactose-Fed Dogs by Aldose Reductase Inhibitors

Peter F Kador, Yoshio Akagi, Yukio Takahashi, Hitoshi Ikebe, Milton Wyman, Jin H. Kinoshita

Research output: Contribution to journalArticle

124 Citations (Scopus)

Abstract

Vascular changes associated with early diabetic retinopathy that include the selective degeneration of pericytes, the formation of microaneurysms and acellular capillaries, and vessel dilation have been experimentally investigated in age-and sex-matched beagle dogs fed a 30% galactose diet and treated with or without the aldose reductase inhibitors sorbinil and/or M79175. Eyes from dogs in each group were periodically enucleated during a 36-month period and their retinal capillaries were examined as trypsin-digested flat preparations. These studies reveal that the destruction of retinal pericytes to form pericyte ghosts is the earliest observable retinal vessel change occurring after 19 to 21 months of galactose feeding. By 24 months, both an irregular distribution of endothelial cell nuclei near pericyte ghosts and the presence of acellular capillaries containing neither endothelial cells nor pericytes can be observed. This was followed by the histologic appearance of microaneurysms after 27 months and the funduscopic appearance of intraretinal hemorrhages after 33 months. Varicose enlargements of capillaries were also observed in the trypsin-digested preparations from dogs fed galactose for 33 to 36 months. All of these changes are linked to the initial aldose reductase-associated destruction of pericytes. The onset and progression of these retinal changes were retarded in a dose-dependent manner with aldose reductase inhibitors.

Original languageEnglish (US)
Pages (from-to)1301-1309
Number of pages9
JournalArchives of Ophthalmology
Volume108
Issue number9
DOIs
StatePublished - Jan 1 1990

Fingerprint

Aldehyde Reductase
Retinal Vessels
Pericytes
Diabetic Retinopathy
Galactose
Dogs
Trypsin
Endothelial Cells
Cell Nucleus
Blood Vessels
Dilatation
Hemorrhage
Diet

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Prevention of Retinal Vessel Changes Associated With Diabetic Retinopathy in Galactose-Fed Dogs by Aldose Reductase Inhibitors. / Kador, Peter F; Akagi, Yoshio; Takahashi, Yukio; Ikebe, Hitoshi; Wyman, Milton; Kinoshita, Jin H.

In: Archives of Ophthalmology, Vol. 108, No. 9, 01.01.1990, p. 1301-1309.

Research output: Contribution to journalArticle

Kador, Peter F ; Akagi, Yoshio ; Takahashi, Yukio ; Ikebe, Hitoshi ; Wyman, Milton ; Kinoshita, Jin H. / Prevention of Retinal Vessel Changes Associated With Diabetic Retinopathy in Galactose-Fed Dogs by Aldose Reductase Inhibitors. In: Archives of Ophthalmology. 1990 ; Vol. 108, No. 9. pp. 1301-1309.
@article{8893c925be534726b0a7db09b24e2240,
title = "Prevention of Retinal Vessel Changes Associated With Diabetic Retinopathy in Galactose-Fed Dogs by Aldose Reductase Inhibitors",
abstract = "Vascular changes associated with early diabetic retinopathy that include the selective degeneration of pericytes, the formation of microaneurysms and acellular capillaries, and vessel dilation have been experimentally investigated in age-and sex-matched beagle dogs fed a 30{\%} galactose diet and treated with or without the aldose reductase inhibitors sorbinil and/or M79175. Eyes from dogs in each group were periodically enucleated during a 36-month period and their retinal capillaries were examined as trypsin-digested flat preparations. These studies reveal that the destruction of retinal pericytes to form pericyte ghosts is the earliest observable retinal vessel change occurring after 19 to 21 months of galactose feeding. By 24 months, both an irregular distribution of endothelial cell nuclei near pericyte ghosts and the presence of acellular capillaries containing neither endothelial cells nor pericytes can be observed. This was followed by the histologic appearance of microaneurysms after 27 months and the funduscopic appearance of intraretinal hemorrhages after 33 months. Varicose enlargements of capillaries were also observed in the trypsin-digested preparations from dogs fed galactose for 33 to 36 months. All of these changes are linked to the initial aldose reductase-associated destruction of pericytes. The onset and progression of these retinal changes were retarded in a dose-dependent manner with aldose reductase inhibitors.",
author = "Kador, {Peter F} and Yoshio Akagi and Yukio Takahashi and Hitoshi Ikebe and Milton Wyman and Kinoshita, {Jin H.}",
year = "1990",
month = "1",
day = "1",
doi = "10.1001/archopht.1990.01070110117035",
language = "English (US)",
volume = "108",
pages = "1301--1309",
journal = "JAMA Ophthalmology",
issn = "2168-6165",
publisher = "American Medical Association",
number = "9",

}

TY - JOUR

T1 - Prevention of Retinal Vessel Changes Associated With Diabetic Retinopathy in Galactose-Fed Dogs by Aldose Reductase Inhibitors

AU - Kador, Peter F

AU - Akagi, Yoshio

AU - Takahashi, Yukio

AU - Ikebe, Hitoshi

AU - Wyman, Milton

AU - Kinoshita, Jin H.

PY - 1990/1/1

Y1 - 1990/1/1

N2 - Vascular changes associated with early diabetic retinopathy that include the selective degeneration of pericytes, the formation of microaneurysms and acellular capillaries, and vessel dilation have been experimentally investigated in age-and sex-matched beagle dogs fed a 30% galactose diet and treated with or without the aldose reductase inhibitors sorbinil and/or M79175. Eyes from dogs in each group were periodically enucleated during a 36-month period and their retinal capillaries were examined as trypsin-digested flat preparations. These studies reveal that the destruction of retinal pericytes to form pericyte ghosts is the earliest observable retinal vessel change occurring after 19 to 21 months of galactose feeding. By 24 months, both an irregular distribution of endothelial cell nuclei near pericyte ghosts and the presence of acellular capillaries containing neither endothelial cells nor pericytes can be observed. This was followed by the histologic appearance of microaneurysms after 27 months and the funduscopic appearance of intraretinal hemorrhages after 33 months. Varicose enlargements of capillaries were also observed in the trypsin-digested preparations from dogs fed galactose for 33 to 36 months. All of these changes are linked to the initial aldose reductase-associated destruction of pericytes. The onset and progression of these retinal changes were retarded in a dose-dependent manner with aldose reductase inhibitors.

AB - Vascular changes associated with early diabetic retinopathy that include the selective degeneration of pericytes, the formation of microaneurysms and acellular capillaries, and vessel dilation have been experimentally investigated in age-and sex-matched beagle dogs fed a 30% galactose diet and treated with or without the aldose reductase inhibitors sorbinil and/or M79175. Eyes from dogs in each group were periodically enucleated during a 36-month period and their retinal capillaries were examined as trypsin-digested flat preparations. These studies reveal that the destruction of retinal pericytes to form pericyte ghosts is the earliest observable retinal vessel change occurring after 19 to 21 months of galactose feeding. By 24 months, both an irregular distribution of endothelial cell nuclei near pericyte ghosts and the presence of acellular capillaries containing neither endothelial cells nor pericytes can be observed. This was followed by the histologic appearance of microaneurysms after 27 months and the funduscopic appearance of intraretinal hemorrhages after 33 months. Varicose enlargements of capillaries were also observed in the trypsin-digested preparations from dogs fed galactose for 33 to 36 months. All of these changes are linked to the initial aldose reductase-associated destruction of pericytes. The onset and progression of these retinal changes were retarded in a dose-dependent manner with aldose reductase inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0025140713&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0025140713&partnerID=8YFLogxK

U2 - 10.1001/archopht.1990.01070110117035

DO - 10.1001/archopht.1990.01070110117035

M3 - Article

VL - 108

SP - 1301

EP - 1309

JO - JAMA Ophthalmology

JF - JAMA Ophthalmology

SN - 2168-6165

IS - 9

ER -